Sarcopenia is a condition characterized by age-related loss of muscle mass and strength. Increasing evidence suggests that patients with sarcopenia have higher rates of coronavirus 2019 (COVID-19) inf
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Modelling predicts that by 2030 over 100 million people will be diagnosed with the progressive inf
BackgroundImmunotherapy combined with chemotherapy has improved outcomes in advanced gastric cancer (GC), but reliable biomarkers to predict clinical benefit remain limited. Metabolomics provides a co
